|Study Type:||Phase Ib|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase 1b clinical trial to examine the role of host genetics in determining the immune response to HIV vaccination (with VRC-HIVDNA016-00-VP and VRC-HIVADV014-00-VP) in twin pairs
HVTN 082 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of VRC-HIVDNA-016-00-VP (DNA) prime / VRCHIVADV014-00-VP (rAd5) boost in twins.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.